• 中文
    • English
  • English 
    • 中文
    • English
  • Login
View Item 
  •   DSpace Home
  • 医学院
  • 医学院-已发表论文
  • View Item
  •   DSpace Home
  • 医学院
  • 医学院-已发表论文
  • View Item
JavaScript is disabled for your browser. Some features of this site may not work without it.

Inhibition of beta-catenin signaling by nongenomic action of orphan nuclear receptor Nur77

Thumbnail
Full Text
Inhibition of beta-catenin signaling by nongenomic action of orphan nuclear receptor Nur77.htm (410bytes)
Date
2012-05
Author
Sun, Z.
Cao, X.
Jiang, M-M
Qiu, Y.
Zhou, H.
Chen, L.
Qin, B.
Wu, H.
Jiang, F.
Chen, J.
Liu, J.
Dai, Y.
Chen, H-F
Hu, Q-Y
Wu, Z.
Zeng, J-Z
曾锦章
Yao, X-S
Zhang, X-K
Collections
  • 医学院-已发表论文 [2568]
Show full item record
Abstract
Dysregulation of beta-catenin turnover due to mutations of its regulatory proteins including adenomatous polyposis coli (APC) and p53 is implicated in the pathogenesis of cancer. Thus, intensive effort is being made to search for alternative approaches to reduce abnormally activated beta-catenin in cancer cells. Nur77, an orphan member of the nuclear receptor superfamily, has a role in the growth and apoptosis of cancer cells. Here, we reported that Nur77 could inhibit transcriptional activity of beta-catenin by inducing beta-catenin degradation via proteasomal degradation pathway that is glycogen synthase kinase 3 beta and Siah-1 independent. Nur77 induction of beta-catenin degradation required both the N-terminal region of Nur77, which was involved in Nur77 ubiquitination, and the C-terminal region, which was responsible for beta-catenin binding. Nur77/DDBD, a Nur77 mutant lacking its DNA-binding domain, resided in the cytoplasm, interacted with beta-catenin, and induced beta-catenin degradation, demonstrating that Nur77-mediated beta-catenin degradation was independent of its DNA binding and transactivation, and might occur in the cytoplasm. In addition, we reported our identification of two digitalis-like compounds (DLCs), H-9 and ATE-i2-b4, which potently induced Nur77 expression and beta-catenin degradation in SW620 colon cancer cells expressing mutant APC protein in vitro and in animals. DLC-induced Nur77 protein was mainly found in the cytoplasm, and inhibition of Nur77 nuclear export by the CRM1-dependent nuclear export inhibitor leptomycin B or Jun N-terminal kinase inhibitor prevented the effect of DLC on inducing beta-catenin degradation. Together, our results demonstrate that beta-catenin can be degraded by cytoplasmic Nur77 through their interaction and identify H-9 and ATE-i2-b4 as potent activators of the Nur77-mediated pathway for beta-catenin degradation. Oncogene (2012) 31, 2653-2667; doi:10.1038/onc.2011.448; published online 10 October 2011
Citation
ONCOGENE,2012,31(21):2653-2667
URI
http://dx.doi.org/10.1038/onc.2011.448
WOS:000304523500005
https://dspace.xmu.edu.cn/handle/2288/15508

copyright © 2002-2016  Duraspace  Theme by @mire  厦门大学图书馆  
About | Policies
 

 

Browse

All of DSpaceCommunities & CollectionsBy Issue DateAuthorsTitlesSubjectsThis CollectionBy Issue DateAuthorsTitlesSubjects

My Account

LoginRegister

copyright © 2002-2016  Duraspace  Theme by @mire  厦门大学图书馆  
About | Policies